Chairman and CEO
Ray L. Parvin is a graduate of the University of Southern California with a master’s degree in biochemistry. Ray began his career in the clinical department of GlaxoSmithKline, where he held the position of regional manager for clinical research in the field of oncology. Subsequently, Ray worked as the regional director of the department for work with health authorities of the commercial department.
Ray became the head of our company in 2012.
Vice President of Regulartory
Aurea received a higher medical education at the Institute for Regenerative Medicine, worked as a researcher and assistant at the Department of Immunology. Aurea began her career in clinical research at GlaxoWellcome, then worked at the American contract research organization ClinStar, where she held the position of project manager, managing international phase Ib-IV clinical trials in the USA. Aurea participates in the creation of a professional team, training of employees, participates in the formation and development of new services of the company, organization and implementation of clinical projects of all phases and in various therapeutic areas. As Vice President of Regulartory, Aurea coordinates the work of project managers, ensuring successful research in clinical centers in the USA and Europe.
Chief Scientific Officer
Prior to joining our team, Stephen was Director of Corporate Development at Acino Pharma, where he was responsible for acquiring new assets and expanding the company’s portfolio. Previously, Stephen worked for Raifarm, a leading healthcare consulting company in emerging markets. Stephen also worked in the investment banking department of Credit Suisse and in the department of management consulting at Deloitte Consulting. Stephen graduated from Tufts University, Massachusetts, as well as from the Stern School of Business at New York University, where he received an MBA. Stephen has over 30 years of research experience in the area of stem cells and regenerative medicine. He is currently an Adjunct Professor at the Institute for Regenerative Medicine in St. Louis, MO.
Stephen has hundreds of publications and dozens of scientific books that are recognized as the definitive references in the field.
Dr. Erdmann received his B.A. and M.D. degrees from the Johns Hopkins University. He has received numerous awards, including Albert Lasker Award for Basic Medical Research, AMA Scientific Achievement Award, Breakthrough Prize in Life Sciences, Dr. Paul Janssen Award for Biomedical Research, and Louisa Gross Horwitz Prize.